by EmpathiCSubstanceS | Nov 5, 2020 | Addiction
Anxiety and depression are common mental health conditions that negatively impact one’s quality of life and increase the risk for developing a variety of chronic physical ailments. Therapists have used various intervention methods to try and treat these conditions,...
by EmpathiCSubstanceS | Nov 4, 2020 | MDMA Sassafras Molly
MDMA, the man-made drug often called ecstasy or molly, has a colorful history. It was patented in 1914 by the German drug company Merck, and set aside for decades. The US Army studied it during the Cold War, perhaps seeking a chemical weapon or interrogation tool....
by EmpathiCSubstanceS | Nov 4, 2020 | MDMA Sassafras Molly
A new study published in the journal Psychopharmacology is presenting a comprehensive look at the long-term efficacy of MDMA-assisted psychotherapy for the treatment of post-traumatic stress disorder (PTSD). The study finds not only do the substantial beneficial...
by EmpathiCSubstanceS | Nov 4, 2020 | MDMA Sassafras Molly
The nation’s leading psychedelics research organization announced on Thursday that it has raised $30 million in donations—including from several notable business leaders outside the drug policy realm—that will enable it to complete a study on using MDMA to treat...
by EmpathiCSubstanceS | Oct 30, 2020 | Depression, Microdosing
Formerly known only to the underground psychedelic community, the practice of taking microdoses of psychedelic drugs for a variety of purported benefits has made its way to the wider mainstream society. Just for starters, microdosers have reported experiencing...
